OTC · NXNN
Nexeon MedSystems Inc.
Healthcare · Medical - Devices
$0.00
Up+$0.00 (+0.00%)
Updated Aug 17, 2026, 12:20 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 78.63K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 265
- Avg. volume
- 4
Price performance
NXNN price history
1M range · 0 trading sessions · Daily adjusted prices
NXNN does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest NXNN news
The latest Smart Investors Daily articles mentioning NXNN.
Stock researchCompany · Overview
NXNN research
Overview
Company profile and research snapshot.
Company profile
Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- —
- Implied upside
- —
- Analysts
- 7
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
